CalciMedica is trading at $0.67, up +8.08%, as U.S. markets rally after July PPI showed no monthly growth, below the expected 0.2% increase.

  • The S&P 500, Nasdaq Composite, and Dow Jones rose 0.70%, 0.91%, and 0.40%, respectively, supporting risk appetite and rate-sensitive growth stocks.
  • In its August 11 earnings report, CalciMedica reported a $0.45 quarterly loss per share versus a $0.26 estimate.